Table 1.
Noticeable prospective randomized controlled trials comparing laparoscopic assisted distal gastrectomy with open distal gastrectomy
Region Country |
East |
West | ||||||
Japan | South Korea | China | Italy | |||||
Author | Kitano et al[30] | Hayashi et al[31] | Lee et al[33] | Takiguchi et al[36] | Kim et al[34,47] | Kim et al[35] | Cai et al[56] | Huscher et al[32] |
Year | 2002 | 2002 | 2005 | 2013 | 2008, 2013 | 2010 | 2011 | 2005 |
Patients | 28 | 28 | 47 | 40 | 164 | 342 | 123 | 59 |
Reconstruction | B-I | B-I | B-I | B-I | B-I | B-I or B-II (mostly) | B-I or B-II | B-II or R-Y |
Lymphadenectomy type | D1 + a | D1 + a | D2 | D1 + b or D2 | D1 + b or D2 | D1 + b or D2 | D2 | D1 or D2 |
Blood Loss | ↓ | NS | NS | ↓ | ↓ | ↓ | ↓ | ↓ |
Operation Time | ↑ | ↑ | ↑ | ↑ | ↑ | NR | ↑ | NS |
Pain or analgesia consumption | ↓ | ↓ | NS | ↓ | ↓ | NR | NR | NR |
Time to Oral Intake or First Flatus | NS | ↓ | NS | ↓ | ↓ | NR | NS | ↓ |
Morbidity | NS | ↓ NC | NS | NS | ↓ | NS | NS | NS |
Pulmonary complications | ↓ NC | ↓ NC | ↓ | NR | NS | 0% NS | ↓ | ↓ NC |
Mortality | 0% NC | 0% NC | 0% NC | 0% NC | 0% NC | About 0% NS | 0% NC | NS |
Length of Stay | NS | ↓ | NS | ↓ | ↓ | NR | NS | ↓ |
Mean number of lymph nodes | ↓4.7-NS | NS | ↓6.3 - NS | NS | ↓6.1 P < 0.01 | NR | NS | ↓3.3 - NS |
5-yr survival | NR | NR | NR | 100% NC | NS | NR | NR | NS |
Upward arrow (↑): increased or more in the laparoscopic assisted distal gastrectomy (LADG) group compared to the open distal gastrectomy (ODG) group; Downward arrow (↓): decreased or less in the LADG group compared to the ODG group. B-I: Billroth I; B-II: Billroth II; R-Y: Roux-en-Y; NS: Not significant; NR: Not reported; NC: Not computed; LADG: Laparoscopic assisted distal gastrectomy; ODG: Open distal gastrectomy.